Skip to main content

Table 1 Population characteristics

From: Micro-RNA-21 (biomarker) and global longitudinal strain (functional marker) in detection of myocardial fibrotic burden in severe aortic valve stenosis: a pilot study

 

Mean

SD

General characteristics

  

Age (year)

75.2

8.06

BSA (m2)

1.8

0.17

Log EUROSCORE (%)

5.9

4.17

EUROSCORE II (%)

2.2

1.13

SAP (mmHg)

139.1

19.00

DAP (mmHg)

71.3

10.03

HR (bpm)

73.5

11.92

 

n

%

Clinical characteristics

  

Female sex

23

63

CHD (</=50 % epicardial coronary)

12

33

COPD

8

22

Anemia

14

38

Chronic kidney dis.

22

61

Diabetes Mell.

8

22

Arterial hypertension

31

86

Dyslipidemia

21

58

 

n

%

Drugs (admission)

  

ACE-inhibitors

15

41

AT-II-inhibitors

10

27

Anti-aldosteronic

2

5

Diuretics

14

38

Calcium-antagonist

6

10

Laboratory data

Mean/Median*

SD/Min–Max**

BNP (pg/mL)

250.9

220.4

GFR (mL/min/1.73 m2)

70.8

28.4

hsTnT (ng/L)

30.4

26.8

miRNA-21 (30 pts)

2.02*

0.02–11.26**

  1. ACE angiotensin converting enzyme, AT-II angiotensin 2 receptor, BNP brain natriuretic peptide, BSA body surface area, CHD coronary heart disease, COPD chronic obstructive pulmonary disease, DAP diastolic arterial pressure, GFR glomerular filtration rate, HR heart rate, SAP systolic arterial pressure